tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
Australian Market

Neuren Pharmaceuticals Limited (NEU) Income Statement

Compare
225 Followers

Neuren Pharmaceuticals Limited Income Statement

Last quarter (Q4 2024), Neuren Pharmaceuticals Limited's total revenue was AU$192.50M, an increase of 1222.79% from the same quarter last year. In Q4, Neuren Pharmaceuticals Limited's net income was AU$134.03M. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20MAU$ 717.00K
Gross Profit
AU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19MAU$ 711.00K
Operating Expenses
AU$ 37.67MAU$ 32.70MAU$ 16.14MAU$ 11.42MAU$ 9.52M
Depreciation and Amortization
AU$ 22.00KAU$ 17.00KAU$ 10.00KAU$ 8.00KAU$ 6.00K
EBITDA
AU$ 175.57MAU$ 199.26MAU$ -1.59MAU$ -8.22MAU$ -8.80M
Operating Income
AU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43MAU$ -9.53M
Other Income/Expenses
AU$ 7.39MAU$ 32.65MAU$ 916.00KAU$ 6.76MAU$ -384.00K
Pretax Income
AU$ 182.94MAU$ 205.14MAU$ -680.00KAU$ -10.99MAU$ -9.91M
Net Income
AU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79MAU$ -9.19M
Per Share Metrics
Basic EPS
AU$ 1.09AU$ 1.24AU$ 0.00AU$ -0.07AU$ -0.09
Diluted EPS
AU$ 1.09AU$ 1.20AU$ 0.00AU$ -0.07AU$ -0.09
Weighted Average Shares Outstanding
127.77M 127.07M 125.97M 117.77M 107.06M
Weighted Average Shares Outstanding (Diluted)
130.78M 130.77M 128.91M 117.77M 107.06M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis